Annals of Internal Medicine is the American College of Physicians' journal. In cancer it carries the US Preventive Services Task Force evidence reviews and modelling studies that set screening ages and intervals, so primary care doctors read it for screening guidance rather than treatment trials.
Publishes the ACP guidance statements, US Preventive Services Task Force evidence reviews and decision-analytic modelling that underpin cancer screening ages and intervals, alongside cohort studies on cancer risk factors. Hybrid access with a strong methods focus (it hosts the PRISMA and other reporting-guideline statements).
One technology page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
The clearest case in cancer screening of a national body acting on the harms rather than the headline. Whether it was right is still argued: testing and localised-stage diagnosis fell, and the long-term effect on metastatic presentation and mortality is the subject of the studies that followed.
One technology page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
Led the NELSON trial, which confirmed CT screening cuts lung cancer deaths in Europe and shaped screening policy.
Epidemiologist whose studies underpin colonoscopy and stool-test screening for bowel cancer.
Lynn Schuchter is a melanoma oncologist who led ASCO in 2023-24.
One technology page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
The clearest case in cancer screening of a national body acting on the harms rather than the headline. Whether it was right is still argued: testing and localised-stage diagnosis fell, and the long-term effect on metastatic presentation and mortality is the subject of the studies that followed.
One technology page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.